High expression of FOXP3 in primary melanoma is associated with tumour progression

British Journal of Dermatology

Volumn 170, Issue 1, 2014, Pages 103-109

  Gerber, A L ^a   Munst A ^a   Schlapbach, C ^a   Shafighi, M ^a   Kiermeir, D ^a   Husler R ^a   Hunger, R E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; CD1 ANTIGEN; CD207 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; T6 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; DENDRITIC CELL; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; VERY ELDERLY; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; SKIN NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD1; DENDRITIC CELLS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LECTINS, C-TYPE; MALE; MANNOSE-BINDING LECTINS; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TUMOR MARKERS, BIOLOGICAL;

EID: 84892420566     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12641     Document Type: Article

References (27)

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF,. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol 2011; 104: 379-85.
2. Ling A, Dawkins R, Bailey M, et al,. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma. Australas J Dermatol 2010; 51: 13-17.
3. Lizee G, Overwijk WW, Radvanyi L, et al,. Harnessing the power of the immune system to target cancer. Annu Rev Med 2013; 64: 71-90.
4. Hodi FS, O'Day SJ, McDermott DF, et al,. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23.
5. Josefowicz SZ, Lu LF, Rudensky AY,. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30: 531-64.
6. Yawalkar N, Tscharner GG, Hunger RE, Hassan AS,. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci 2009; 54: 99-105.
7. Schlapbach C, Yawalkar N, Hunger RE,. Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol 2009; 61: 58-65.
8. Erdag G, Schaefer JT, Smolkin ME, et al,. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 2012; 72: 1070-80.
9. Mizukami Y, Kono K, Kawaguchi Y, et al,. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 2008; 98: 148-53.
10. Senovilla L, Vacchelli E, Galon J, et al,. Trial watch: prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology 2012; 1: 1323-43.
11. Balch CM, Gershenwald JE, Soong SJ, et al,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
12. Restifo NP, Dudley ME, Rosenberg SA,. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 2012; 12: 269-81.
13. + cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother 2010; 59: 909-19.
14. Naito Y, Saito K, Shiiba K, et al,. CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491-4.
15. Jensen TO, Schmidt H, Møller HJ, et al,. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 2012; 118: 2476-85.
16. Karagiannis P, Gilbert AE, Josephs DH, et al,. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest 2013; 123: 1457-74.
17. Balkwill F, Coussens LM,. Cancer: an inflammatory link. Nature 2004; 431: 405-6.
18. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7.
19. Jensen SM, Twitty CG, Maston LD, et al,. Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence. J Immunol 2012; 189: 767-76.
20. low regulatory T cells are an independent predictor of advanced melanoma. Pigment Cell Melanoma Res 2013; 26: 280-3.
21. Ma MW, Medicherla RC, Qian M, et al,. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol 2012; 25: 1000-10.
22. Sakaguchi S, Miyara M, Costantino CM, Hafler DA,. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
23. Thompson JF, Soong SJ, Balch CM, et al,. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 2011; 29: 2199-205.
24. Chu CC, Ali N, Karagiannis P, et al,. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012; 209: 935-45.
25. Ascierto PA, Grimaldi AM, Acquavella N, et al,. Future perspectives in melanoma research. Meeting report from the 'Melanoma Bridge. Napoli, December 2nd-4th 2012'. J Transl Med 2013; 11: 137.
26. Galon J, Pages F, Marincola FM, et al,. The immune score as a new possible approach for the classification of cancer. J Transl Med 2012; 10: 1.
27. Magin P, Pond D, Smith W, et al,. Reliability of skin-type self-assessment: agreement of adolescents' repeated Fitzpatrick skin phototype classification ratings during a cohort study. J Eur Acad Dermatol Venereol 2012; 26: 1396-9.